These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8010683)

  • 21. Database issues in object-oriented clinical information systems design.
    Chu SC; Thom JB
    Stud Health Technol Inform; 1997; 46():376-82. PubMed ID: 10175427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of cell culture with downstream purification: a case study.
    Berthold W; Kempken R
    Cytotechnology; 1994; 15(1-3):229-42. PubMed ID: 7765936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production and analysis of proteins by recombinant DNA technology.
    Pestka S
    Bioprocess Technol; 1990; 7():235-65. PubMed ID: 1366823
    [No Abstract]   [Full Text] [Related]  

  • 24. Periodic counter-current chromatography -- design and operational considerations for integrated and continuous purification of proteins.
    Godawat R; Brower K; Jain S; Konstantinov K; Riske F; Warikoo V
    Biotechnol J; 2012 Dec; 7(12):1496-508. PubMed ID: 23070975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extraction and purification methods in downstream processing of plant-based recombinant proteins.
    Łojewska E; Kowalczyk T; Olejniczak S; Sakowicz T
    Protein Expr Purif; 2016 Apr; 120():110-7. PubMed ID: 26742898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput process development for recombinant protein purification.
    Rege K; Pepsin M; Falcon B; Steele L; Heng M
    Biotechnol Bioeng; 2006 Mar; 93(4):618-30. PubMed ID: 16369981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Micro biochemical engineering to accelerate the design of industrial-scale downstream processes for biopharmaceutical proteins.
    Titchener-Hooker NJ; Dunnill P; Hoare M
    Biotechnol Bioeng; 2008 Jun; 100(3):473-87. PubMed ID: 18438873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aqueous two-phase systems for protein separation: phase separation and applications.
    Asenjo JA; Andrews BA
    J Chromatogr A; 2012 May; 1238():1-10. PubMed ID: 22494642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Principles of the design and operational considerations of large scale high performance liquid chromatography (HPLC) systems for proteins and peptides purification.
    Wisniewski R
    Bioseparation; 1992; 3(2-3):77-143. PubMed ID: 1369243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning technologies for protein expression and purification.
    Hartley JL
    Curr Opin Biotechnol; 2006 Aug; 17(4):359-66. PubMed ID: 16839756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An expert system designed as a tutoring tool in cervical cytology: TTCC-1 system.
    Tang ZY; Savino A; Wong EK; Koss LG; Shaw LG
    Anal Quant Cytol Histol; 1988 Dec; 10(6):417-22. PubMed ID: 3064763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generic chromatography-based purification strategies accelerate the development of downstream processes for biopharmaceutical proteins produced in plants.
    Buyel JF; Fischer R
    Biotechnol J; 2014 Apr; 9(4):566-77. PubMed ID: 24478119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of prone-to-aggregate proteins.
    Lebendiker M; Danieli T
    FEBS Lett; 2014 Jan; 588(2):236-46. PubMed ID: 24211444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economics of recombinant antibody production processes at various scales: Industry-standard compared to continuous precipitation.
    Hammerschmidt N; Tscheliessnig A; Sommer R; Helk B; Jungbauer A
    Biotechnol J; 2014 Jun; 9(6):766-75. PubMed ID: 24706569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein purification: aspects of processes for pharmaceutical products.
    Berthold W; Walter J
    Biologicals; 1994 Jun; 22(2):135-50. PubMed ID: 7917230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An insight into fusion technology aiding efficient recombinant protein production for functional proteomics.
    Yadav DK; Yadav N; Yadav S; Haque S; Tuteja N
    Arch Biochem Biophys; 2016 Dec; 612():57-77. PubMed ID: 27771300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-step cell disruption for the extraction of membrane-associated recombinant protein from Saccharomyces cerevisiae.
    Chi WK; Ku CH; Chang CC; Tsai JN
    Ann N Y Acad Sci; 1994 May; 721():365-73. PubMed ID: 8010685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimized expression in Pichia pastoris eliminates common protein contaminants from subsequent His-tag purification.
    Chen Y; Li Y; Liu P; Sun Q; Liu Z
    Biotechnol Lett; 2014 Apr; 36(4):711-8. PubMed ID: 24322766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microplate-Based Method for High-Throughput Screening (HTS) of Chromatographic Conditions Studies for Recombinant Protein Purification.
    Carvalho RJ; Cruz TA
    Methods Mol Biol; 2018; 1674():211-220. PubMed ID: 28921440
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.